National Institutes of Health Funding for Tuberculosis Comorbidities Is Disproportionate to Their Epidemiologic Impact

Open Forum Infect Dis. 2023 Dec 18;11(1):ofad618. doi: 10.1093/ofid/ofad618. eCollection 2024 Jan.

Abstract

Tuberculosis (TB) is a leading infectious killer worldwide. We systematically searched the National Institutes of Health Research, Portfolio Online Reporting Tools Expenditures and Results (RePORTER) website to compare research funding for key TB comorbidities-undernutrition, alcohol use, human immunodeficiency virus, tobacco use, and diabetes-and found a large mismatch between the population attributable fraction of these risk factors and the funding allocated to them.

Keywords: HIV; comorbidities; funding; tuberculosis; undernutrition.